STAA
STAAR Surgical Company
NASDAQ: STAA · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$26.36
+3.45% today
Updated 2026-04-30
Market cap
$1.26B
P/E ratio
—
P/S ratio
5.27x
EPS (TTM)
$-1.62
Dividend yield
—
52W range
$16 – $31
Volume
1.3M
STAAR Surgical Company (STAA) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-33.60%
Operating margin
-18.90%
ROE
-21.70%
ROA
-5.95%
Debt/equity
0.11x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $56.28M | $-15.04M | 46.97% | -24.17% | -26.73% |
| 2007 | $59.36M | $-16.00M | 49.30% | -23.78% | -26.95% |
| 2008 | $74.89M | $-23.20M | 53.55% | -27.22% | -30.97% |
| 2009 | $75.34M | $-6.20M | 55.60% | -4.95% | -8.23% |
| 2010 | $54.96M | $53000.00 | 63.82% | -4.73% | 0.10% |
| 2011 | $62.77M | $1.35M | 67.50% | 4.43% | 2.15% |
| 2012 | $63.78M | $-1.76M | 69.44% | -1.91% | -2.76% |
| 2013 | $72.22M | $398000.00 | 69.67% | 0.97% | 0.55% |
| 2014 | $74.99M | $-8.39M | 65.11% | -10.70% | -11.19% |
| 2015 | $77.12M | $-6.53M | 68.36% | -6.92% | -8.47% |
| 2016 | $82.43M | $-12.13M | 70.81% | -15.35% | -14.71% |
| 2017 | $90.61M | $-2.14M | 70.94% | -4.01% | -2.36% |
| 2018 | $123.95M | $4.97M | 73.83% | 5.32% | 4.01% |
| 2019 | $150.19M | $14.05M | 74.54% | 7.89% | 9.35% |
| 2020 | $163.46M | $5.91M | 72.41% | 4.14% | 3.62% |
| 2021 | $230.47M | $27.51M | 77.51% | 14.47% | 11.94% |
| 2022 | $284.39M | $39.66M | 78.55% | 15.40% | 13.95% |
| 2023 | $322.42M | $21.35M | 78.36% | 8.71% | 6.62% |
| 2024 | $313.90M | $-20.21M | 76.32% | -4.02% | -6.44% |
| 2025 | $239.44M | $-80.45M | 73.88% | -19.16% | -33.60% |